We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Analyses from Phase III ALSYMPCA Trial Presented at ESMO 2012

News   Oct 01, 2012

 
New Analyses from Phase III ALSYMPCA Trial Presented at ESMO 2012
 
 
 

RELATED ARTICLES

Novel Drug May Reverse Breast Cancer Hormone Therapy Resistance

News

A novel drug based on a natural compound found in cruciferous vegetables could hold the key to reversing resistance to breast cancer hormone therapy, according to new research.

READ MORE

Working Towards Better Anti-cancer Drugs

News

Most cancers are caused by a large variety of factors that vary from one person to another. To unravel this complexity, genes that contribute to the development of a respective cancer must be identified. Such genes are called oncogenes.

READ MORE

Bone Marrow-on-a-Chip Provides New Research Directions for Bone Marrow Disease

News

A new research tool that mimics the behavior of diseased bone marrow provides a new strategy for understanding the bone marrow disease, Shwachman-Diamond syndrome (SDS), and hopefully, developing new treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE